| ||||
Psoriasis
by
Jill Shuman, MS, RD, ELS DefinitionPsoriasis is a chronic, inflammatory skin disease. Knees, elbows, scalp, trunk, and nails are the most commonly affected areas. There are several types of psoriasis:
CausesThe cause of psoriasis is unclear. Signals from a defect in the immune system may result in an overgrowth of skin cells. Because the cells grow faster than they can be shed, they pile up on the skin's surface. The excess skin cells are thought to cause the silvery white scales that are characteristic of plaque-type psoriasis. Risk Factors TOPA risk factor is something that increases your chance of getting a disease or condition. Risk factors for this condition include:
Symptoms TOPThe red, thickened, and rough patches of psoriasis may occur anywhere, but are commonly found on the scalp, elbows, knees, palms, and soles. Other symptoms include:
The skin may also be sore, burning, or itchy depending on the type of psoriasis. Diagnosis TOPThe doctor will ask about your symptoms and medical history. A physical exam will be done including and examination of your skin and nails will be examined. There are no specific blood tests or diagnostic procedures for psoriasis. Sometimes a skin biopsy will be done to confirm the diagnosis. Treatment TOPTreatment is based on:
Topical TreatmentMany patients respond very well to treatments applied directly to the skin. Topical treatments include:
Photo (Light) TherapyIf psoriasis covers more than 30% of the body, it is difficult to treat with topical medications alone. Daily, short, nonburning exposure to sunlight clears or improves psoriasis in many people. Sunlight is often included among initial treatments. A more controlled form of artificial light treatment (UVB phototherapy) is often used in cases that are more widespread. Alternatively, psoriasis can be treated with ultraviolet A (UVA light) and psoralen. Psoralen is an oral or topical medication that makes the body more sensitive to light. This treatment is known as PUVA. Phototherapy can be very effective in controlling psoriasis but it requires frequent treatments. It may cause side effects such as nausea, headache, and fatigue, burning, and itching. Both UVB and PUVA may increase the person's risk for squamous cell and, possibly, melanoma skin cancers. It is unclear whether UVB increases the risk of skin cancer. Systemic TreatmentFor more severe types of psoriasis, doctors may prescribe a number of other powerful medications, which can be effective, but are associated with side effects that are more serious. These include:
Newer medicines include biologic agents, which affect a part of the body's immune response. For example, ustekinumab (Stelara) is a recently approved drug that targets certain cells in the immune system that cause inflammation. Prevention TOPAvoiding physical trauma to the skin, infections, and cold, dry temperatures may help reduce flare-ups in people with the condition. Your doctor may advise you to avoid certain foods if they appear to make your psoriasis worse. RESOURCES:National Institutes of Health http://www.nih.gov/ National Psoriasis Foundation http://www.psoriasis.org/ CANADIAN RESOURCES:Canadian Dermatology Association http://www.dermatology.ca/ Psoriasis Society of Canada http://www.psoriasissociety.org/ References:
de Prost Y. New topical immunological treatments for psoriasis.
J Eur Acad Dermatol Venereol
. 2006;20(suppl 2):80-82.
Kasper DL, Braunwald E, Fauci A, Hauser S, Longo D, Jameson JL.
Harrison's Principles of Internal Medicine
. 16th
ed. McGraw-Hill; 2000.
Lebwohl M. Psoriasis.
American Academy of Dermatology website. Available at:
http://www.aad.org/education/students/psoriasis.htm
. Accessed July 15, 2009.
Moderate to severe psoriasis: biologic drugs.
National Psoriasis Foundation website. Available at:
http://www.psorias...
. Accessed October 2, 2009.
Moderate to severe psoriasis: systemic medications—methotrexate.
National Psoriasis Foundation website. Available at:
http://www.psoriasis.org/netcommunity/sublearn03_severe_metho
. Accessed October 2, 2009.
Psoriasis vulgaris. DynaMed website. Available at:
http://www.ebscohost.com/dynamed/what.php
. Updated August 27, 2009. Accessed September 18, 2009.
Tierney LM, McPhee SJ, Papadakis MA.
Current Medical Diagnosis and Treatment
. 44th ed. McGraw Hill/Appleton & Lange; 2005.
Varani J, Bhagavathula N, Ellis CN, Pershadsingh HA.
Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease.
Expert Opin Investig Drugs
. 2006;15:1453-1468.
10/2/2009 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed/what.php
: FDA approves new drug to treat psoriasis. US Food and Drug Administration website. Available at:
http://www.fda.gov...
. Published September 25, 2009. Accessed October 2, 2009.
Last reviewed September 2012 by Purvee S. Shah, MD Last Updated: 02/25/2013 | ||||
| ||||